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Growth of the vertebrate heart during embryonic and
fetal life is characterized by hyperplasia of myocardial
cells. Shortly after birth, myocardial cells lose the ca-
pability of dividing, and further growth of the heart is
due to myocardial cell hypertrophy and nonmuscle cell
hyperplasia. This process results in a 30- to 4O-fold in-
crease in volume of individual myocardial cells during
normal postnatal growth and maturation. The transition
from hyperplastic to hypertrophic growth is related to
formation of binucleated myocardial cells as a result of
karyokinesis without cytokinesis. The molecular mech-
anism of this transition is uncertain.
The response of the heart to increased metabolic de-
mands or an increased work load depends on the age of
the animal at the time when the stress is imposed. In-
creased myocardial work loads in fetal or early neo-
natal life lead to cardiac enlargement by causing an in-
creased rate of hyperplasia of myocardial cells or
continuation of hyperplasia beyond the normal period
Normal Cardiac Growth
The cellular mechanism of hypertrophy is determined by
the age of the subject at the time that the stimulus to hy-
pertrophy is introduced and the pattern of normalmyocardial
growth at that age. During fetal and early neonatal life, the
hyperplastic phase (birth to 4 days postpartum) of myo-
cardial growth, the heart enlarges by increasing the number
of mononucleated myocardial cells (1-5). Estimates of myo-
cardial cell numbers in neonatal and adult hearts of various
species based on morphologic techniques have shown that
the number of myocardial cells present in the adult is sub-
stantially greater than that found at birth, supporting the
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of hyperplastic growth. In contrast, imposition of in-
creased loads on the hearts of older animals results in
cardiac hypertrophy due to enlargement of myocardial
cells and hyperplasia of nonmuscular components. In
addition to cellular enlargement, structural remodeling
of the myocardial cells and of the chambers of the heart
occurs during the development of hypertrophy.
Important stimuli of cardiac hypertrophy include in-
creased systolic force or tension generated by the myo-
cardial fibers (pressure overload), increased end-dia-
stolic wall stress (volume overload) and neurohumoral
factors such as increased circulating catecholamines or
discharge of cardiac sympathetic nerves, or both, acti-
vation ofthe renin·angiotensin system and increased lev-
els of thyroxine and growth hormone. Myocardial growth
factors may provide a biochemical basis for genetically
based myocardial hypertrophy.
(J Am Coli CardioI1985;5:57B-65B)
notion that myocardial cells undergo hyperplasia during growth
(6). There is an approximately twofold increase in total
myocardial cell number from birth to age 21 days. In con-
trast, normal heart growth from age 21 days to adulthood
appears to be due to hypertrophy of myocardial cells.
Mononucleated versus multinucleated myocardial
cells. At birth almost all myocardial cells are mononu-
cleated, but adult hearts have multinucleated myocardial
cells. Adult members of most mammalian species have pre-
dominantly binucleated myocardial cells (7). In human beings,
18 to 25% of myocardial cells are binucleated, but there is
a high incidence of polyploidy (Table 1). Furthermore, the
incidence of polyploidy in human myocardial cells increases
with advancing age and the development of hypertro-
phy (8).
Several mechanisms by which mononucleated myo-
cardial cells could become binucleated have been proposed:
I) fusion of mononucleated cells (9), 2) amitotic nuclear
division (10), and 3) mitotic division of nuclei without cy-
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Table 1. Ploidy Frequencies of Left Ventricular Myocytes of Various Mammalian Species
Species 2c 4c 8c 16c 32c
Rat ." v ~
6'/2 weeks 96 417 to 18 weeks 98 2
''''bit}Cat 93 to98 2 to7Dog adult \.
...
Cattle
Pig, adult 82 14 4 2.8
Monkey, Rhesus
3 to4 years 88 8 to 14
8 to 10 years 29 55 16
Human heart weight
150 g 45 47 8
250 to500 g 20 50 35 5
500 to750 g oto 10 10 to40 45 to65 15 to30 oto5
(Reproduced from zak R. Development and proliferative capacity ofcardiac muscle cells. Circ Res 1974;
34/35 [suppl 11]:11-21 , with permission ofthe American Heart Association, Inc .)
toplasmic separation (karyokinesis without cytokinesis)
u.r.m.
Fusion of myocardial cells. The proposal of fusion of
myocardial cells is based on observationsfrom skeletalmus-
cle systems (Fig. 1). Skeletal muscle cells originate from
presumptive myoblasts, a group of spindle-shaped mono-
nucleated cells with prominent mitotic activity but no spe-
cific muscle proteins. Myoblasts then fuse with one another
to form a multinucleated fiber, known as a myotube, which
Figure 1. Scheme of muscle cell differentiation in skeletal and
cardiac muscle. (Reproduced from ZakR; Development and pro-
liferative capacity ofcardiac muscle cells. Circ Res 1974;34/35[suppl
11]:11-19, with permission oftheAmerican Heart Association, Inc.)
SKELETAL MUSCLE I HEART
lATERAl PLATE MESODERM I SPLANCHNIC MESODERM
0- PROLIFERATE! ,--/\
'" I MYOCARDIAL
~~ I R~N
aUANTAl(~-J i ,"OCACfi '£.'0'
MITOSIS (1) MYOBlASTS! ~RJ t CONNECTIVE
I '1;J Q2)~ TISSUE
1 \ CEllS~~~--~ IMvCECAi'S riJf'~.~, . )
FUSION !-
I @)<!D@>~
~~:'~~lMY01UlE! ~
.......... J! +
\ SATElliTE CElli ~JMYOCYTES
~Ii;\illli.',fl.l ,'} Myo·1
.s - -- FIBER I
I
matures into the myofiber. The mature myofiber contains
within its basement membrane a group of undifferentiated
cells known as "satellite cells" that have myogenic prop-
erties and serve as a source of nuclei in postnatal growth
(12). Satellite cells are capable of giving rise to myoblasts
or additional satellite cells. Myocardial cells also have the
potentialto fuse in vitro, formingmultinucleated myocardial
cells (10,13) . Thus, cell fusion must be considered as a
possible mechanism for formation of multinucleated myo-
cardial cells.
Amitotic nuclear division. This has been adduced to ex-
plain the increase in number of myocardial cell nuclei in
adults compared with neonates. Evidence for this mecha-
nism is indirect and is based on morphologic obsetvations
of the appearanceof nuciei in the hearts of growing animals
(7). Polyploidnuclei must be produced for amitotic nuclear
splitting to occur (14). Because polyploid nuclei have not
been observed in the rat heart in the early neonatal period,
it is unlikely that binucleated myocardial cells in neonatal
rats form as a resultof amitotic splittingof polyploid nuclei.
DNA synthesis. Differentiated myocardial cells can
synthesize DNA and undergo mitosis (15,16). Thus, con-
tinued mitotic division of a riucleus without cytoplasmic
separation (karybkinesis without cytokinesis) may be re-
sponsible for the formation of multinucleated myocardial
cells. Supportfor this mechanismis basedon theobservation
of active myocardial cell DNA synthesis and mitosis in the
early neonatalperiod(17) . During the transitionperiod from
mono- to binucleatedcells in the rat heart (age 6 to 14days),
mitotic figures occur in differentiated myocardial cells (3).
The percent of myocardial cells observed in mitosis is ap-
proximately 2% at birth, decreasing to less than 0 .1% by
age 4 weeks (Fig. 2) (14).
Role of age. DNA synthesis is active in rats at birth,
then decreases progressively and essentially stops by age 3
-2 -1 0 I 2 3 4 !5 6 7 8 9
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Figure 2. Mitotic activity of various cell types at
different stages of rat growth: I = hepatocytes,
2= heartconnective tissuecells, 3 = heartmyocytes
and4 = skeletal muscle (tongue). (Reproduced with
permission from Zak R. Development and prolif-
erative capacity of cardiac muscle cells. Circ Res
1974;34/35 [suppl II]:II-18, with permission of the
American Heart Association, Inc.)
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weeks (18). Enzymes essential for DNA replication have
been shown to be lost from isolated rat myocardial cells by
age 3 weeks (19). Progressive decreases in alpha-DNA poly-
merase and chromatin transcriptase activities have been de-
scribed with advancing age, while beta- and gamma-DNA
polymerase remain unchanged (20) . The time course of
decrease in activity of enzymes necessary for DNA repli-
cation is parallel with the restriction in proliferative capacity
of cardiac myocytes (20) . One explanation of these findings
is that there is a decrease in DNA accessibility for gene
transcription, resulting in loss of mitotic potential by myo-
cardial cells. Bugaisky and Zak '(21) postulated that a cha-
lone-like molecule accumulates in the myocardial cell dur-
ing growth. Once this molecule reaches a critical concen-
tration, DNA synthesis shuts off. If, however, the heart is
stressed before the critical chalone levels are reached, the
myocardial cell can still synthesize enzymes necessary for
stimulating DNA synthesis, thus resulting in further mitosis
and extension of the period of hyperplastic growth (21) .
Enlargement of myocardial cells. Once DNA repli-
cation and mitosis in myocardial cells cease , further cardiac
growth is accomplished by enlargement of myocardial cells
and hyperplasia of nonmuscular components of the myo-
cardium . During the hypertrophic growth phase, which be-
gins at approximately 15 days postpartum in the rat, there
is stabilization in the percent of binucleated cells, negligible
myocardial cell DNA activity and no significant increase in
myocardial cell numbers . Nevertheless, the heart continues
to increase in weight, and there is a significant increase in
myocardial cell length from age 15 to 28 days with a con-
comitant increase in myocardial cell volume. The volume
of individual myocardial cells increases 30- to 40-fold dur-
ing normal postnatal growth and maturation in the period
after cessation of hyperplastic growth .
Effects of Stress on Neonatal Cardiac Growth
The mechanism by which the neonatal heart responds to
stress is fundamentally different from that of the adult heart.
In the transitional growth phase or early in the hypertrophic
growth phase, the neonatal rat myocardial cell can reinitiate
DNA synthesis when stressed even though mitotic index,
alpha-DNA polymerase and thymidine kinase levels are sim-
ilar to those measured in normal adult hearts (3,7,17) . Re-
newed DNA synthesis has been interpreted as indicative of
myocardial cell hyperplasia (2,7,17) . Alternatively, in-
creased myocardial cell DNA could reflect cell hypertrophy
with increased numbers of bi-, tri- and tetranucleated cells.
The increased DNA observed in stressed neonatal hearts has
not been observed in adult rat hearts and, therefore, rep-
resents a form of cardiomegaly that is unique to the neonate .
Effects of Stress on Cardiac
Growth in Adults
Increased myocardial work load in adult animals leads
to enlargement of myocardial cells and to hyperplasia of
nonmuscular components of the myocardium. There is no
mitotic activity in myocardial cells, but increased DNA
synthesis does occur in nonmuscular components of the
myocardium (5).
Work load and myocardial cell size. Numerous studies
have demonstrated that in the presence of augmented work
load on the heart with associated increases in heart weight ,
there is a detectable increase in the cross-sectional area or
diameter of myocardial cells (22) . Recent reports (23) have
also shown increases in myocardial cell length in the hy-
pertrophied heart. Relative changes in length and width of
myocardial cells may be related to the nature of the work
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overload placed on the heart. Myocardial cells appear to
undergo a relatively greater increase in length than in width
in hearts subjected to a volume overload and cardiac dila-
tion, while a greater increase in width occurs in hypertrophy
due to a pressure overload unaccompanied by chamber di-
lation (22).
Biochemical changes. Increased RNA polymerase ac-
tivity is one of the earliest biochemical changes observed
in developing cardiac hypertrophy in adult animals, occur-
ring within 12 to 24 hours after aortic constriction in the
rat (24). This enzyme is responsible for RNA synthesis,
which in tum produces ribosomes, transfer RNA and mes-
senger RNA. Increased RNA concentration per gram of
heart tissue and increased total cardiac RNA content, re-
flecting an increased number of ribosomes, have been ob-
served in cardiac hypertrophy induced by a variety of ex-
perimental procedures (24). When the sustained phase of
cardiac hypertrophy is reached, total RNA content decreases
below the peak levels observed in developing hypertrophy
but still remains above control levels (25). Heart weight and
total protein content are higher than those of control animals.
Mitochondrial versus cell volume ratios. Within 48
hours after aortic banding, mitochondrial mass increases.
The increment in mitochondrial mass occurs more rapidly
than the increase in myofibrillar components of the cell, so
there is an increased mitochondria to cell volume ratio early
in the course of developing hypertrophy (26). When the
heart reaches a state of stable compensated hypertrophy, the
mitochondria to myofibril ratio normalizes (27). If myo-
cardial failure develops, a decreased mitochondrial to cell
volume ratio and an increased number of small (immature)
mitochondria are found, suggesting that the cell attempts to
compensate for the adenosine triphosphate (ATP) deficiency
by rapidly producing immature forms of mitochondria (22).
Myofibrillar changes. Morphologic changes in myofi-
brils appear as hypertrophy develops. The most striking of
these is expansion of Z-band material. The intercalated disc
in hypertrophied myocardial cells has an increased surface
area and enhanced folding of its transverse segments (22).
Multiple intercalated discs that have been described as trans-
verse disc areas separated by 1 to 10 sarcomeres within a
single cell have been found in hypertrophied human and
animal hearts. These are a morphologic expression of in-
creased intercalated disc area in the hypertrophied myo-
cardial cell and are thought to beinvolved in sarcomerogenesis.
In summary, imposition of increased loads on the hearts
of adult animals results in cardiac hypertrophy due to en-
largement of myocytes and hyperplasia of nonmuscular
components of the myocardium. In addition to cellular en-
largement, structural remodeling of the myocyte, including
alterations in relative proportions of cellular organelles and
in the ultrastructure of individual organelles, occurs during
the development of hypertrophy in the adult heart. The
precise nature of the cellular remodeling process is depen-
dent on the stimulus to hypertrophy.
Pathogenesis of Ventricular Hypertrophy
Mechanical Factors
Heart size and left ventricular wall tension and pres-
sure. Cardiac muscle normally grows to compensate for
the work load imposed on the ventricle. Classically, the
most important factor mediating cardiac hypertrophy has
been thought to be the systolic force or tension generated
by the myocardial fibers (28). The relations among left
ventricular wall tension, intracavitary pressure and heart size
can be expressed by the law of Laplace. Assuming that the
ventricle is a thin-walled sphere, wall tension (Tw) is pro-
portional to pressure (P) and the radius of curvature (r) (29):
T; = Pr/2. For spheres with a significant wall thickness
(WT) , this becomes T; = Pr/2WT or P = T; x 2WT/r
(30). When a chronically increased pressure load is imposed
on the ventricle, left ventricular wall thickness increases so
that the left ventricular peak systolic wall stress remains
unchanged and within normal limits (31-33). Thus, P (pres-
sure) = a constant (K) x WT/r, so that the ratio of WT/r,
or relative wall thickness of the left ventricle, is directly
proportional to the intracavitary pressure, and in cases in
which left ventricular outflow tract obstruction is absent, to
the systolic blood pressure (30).
Pressure-overloaded left ventricles tend to develop con-
centric hypertrophy and an increased ratio of wall thickness
to radius of the left ventricular cavity (Fig. 3) (28). These
changes occur whether the increased pressure load is due
to aortic stenosis, systemic hypertension or some other le-
sion. In contrast, volume-overloaded left ventricles develop
eccentric hypertrophy and proportionate increases in left
ventricular radius and wall thickness so that relative wall
thickness remains within the normal range. In this situation
if systolic pressure remains unchanged, wall thickness and
the radius of the curvature increase proportionally, causing
a "magnification" of the left ventricle.
There are exceptions to these general rules governing
patterns of left ventricular hypertrophy. For example, Sav-
age et al. (34) reported ventricular septal thickening that
was disproportionate to the left ventricular free wall thick-
ness in a small proportion (4%) of hypertensive patients.
The demonstration of asymmetric septal hypertrophy in hy-
pertensive hearts raises the question of whether this cardiac
abnormality is etiologically related to the hypertension or
whether it represents an independent genetically mediated
event. Further study is needed to resolve this issue.
Alterations and pattern of ventricular hypertrophy.
To examine the role of alterations in systolic and diastolic
wall stresses in influencing the pattern and extent of left
ventricular hypertrophy in human beings, Grossman et al.
(33) examined systolic and diastolic wall stresses in a series
of patients with a normal or chronically pressure-overloaded
or chronically volume-overloaded left ventricle (Fig. 3).
Left ventricular systolic pressure was increased only in the
pressure-overloaded group, while left ventricular diastolic
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together. Derivation of the equations representing this re-
lation (Fig . 5) permits calculation of an average meridional
or longitudinal stress throughout the cardiac cycle from si-
multaneous echocardiographic and invasive measurements
of left ventricular pressure, wall thickness and radius (33).
Figure 6 is an example of wall stress measurements obtained
throughout the cardiac cycle in a representative normal sub-
ject. Peak systolic meridional stress usually occurred early
in ejection (40 to 60 ms after aortic valve opening); end-
diastolic measurements were taken at the time of the peak
a. 7T(R2-R2)=P7TR?
mOl I
O"m =PRj/2h(1 +h/2Rjl
Figure 5. Diagrammatic representation of an idealized left ven-
tricular chamber in coronal section, looking from the front (left)
and above (right). Wall thickness (h), inner radius (R) and outer
radius (Ro) are required to calculate meridional wall stress (am).
This is accomplished by equating the meridional wall forces (am
x 7T [Ro2-R?D to the pressure (P) loading (P7TR?), since these
mustbe exactly equal if the ventricle is to hold together. The same
calculation applies for either an ellipsoid or a spherical model.
(Reproduced with permission from Grossman W, et at. [33].)
Figure 4. Ratioof left ventricularwall thickness to internalradius
(h/R) at end-diastole (clear bars) and at the time of peak systolic
stress (hatched bars) . Wallthickness/internal radius ratio is nor-
mal in patients with left ventricular volume overload, but signif-
icantly increased in patients with pressure overload. Bars and
brackets represent mean values and standard errors, respectively .
(Reproduced with permission from Grossman W, et al. [33].)
pressure was increased equally in both the pressure-over-
loaded and the volume-overloaded group. All patients were
well compensated in terms of systolic performance, and left
ventricular mass was increased to more than twice normal
in both patient groups, indicating significant hypertrophy.
Left ventricular wall thickness was significantly increased
in both groups, but was disproportionately increased in the
group with pressure overload, indicating the presence of
concentric hypertrophy. The ratio of left ventricular wall
thickness to internal radius of the left ventricle was normal
in patients with left ventricular volume overload but sig-
nificantly increased in patients with pressure overload (Fig.
4). These differences were noted when measurements were
made at end-diastole as well as at the time of peak systolic
stress.
Average meridional or longitudinal stress was calculated
throughout the cardiac cycle as part of the study of Gross-
man et al. (33) . Figure 5 illustrates the theoretical basis for
such calculations. Left ventricular wall stress is a function
of chamber size and configuration, thickness of the ven-
tricular wall and intracavitary pressure. Assuming that the
ventricle is either an ideal ellipsoid or a perfect sphere,
average meridional stress (am) is defined as the force per
unit area acting at the midplane to the heart in the direction
of the apex to base length (33). Meridional wall forces must
be equal to the pressure load if the ventricle is to hold
Figure 3. Left ventricular (LV) pressure, left ventricular mass
index (LVMI), left ventricular wall thickness, ratio of wall thick-
ness to internal radius (h/R) at end-diastole and meridional left
ventricular wall stress (am) in patients with a normal heart com-
pared with those with chronic left ventricularpressureoverload or
volumeoverload. Only patients with chronic left ventricularpres-
sure or volume overload who were well compensatedand had no
depression of systolic function (left ventricular ejection fraction)
were included. (Reproduced with permission from Grossman W,
et al. [33].)
~
LV PRESSURE 117t7/10tl 226t6'/23t3' 138t 7123t2'(mmHg)
LVMI 71t8 206 t 17' 196 t 17'
(gm/m2)
LV WALL 8.2 t .6 15.2 t .9' IO.6t .5'THICKNESS(mm)
h/R .34 t.03 .56 t.05* 33t02
O"m (103 dy_/cm21
PEAK SYSTOLIC 151 t4 161 t 24 175t7
ENDDIASTOLIC 17t2 23t 3 41t3*
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group (220 ± 6 mm Hg, p < 0.01) but not in the volume
overload group (139 ± 7 mm Hg, p = NS) compared with
values in normal subjects (117 ± 7 mm Hg). Left ventric-
ular end-diastolic pressure was significantly increased in
both pressure overload (23 ± 3 mm Hg, p < 0.001) and
volume-overload (24 ± 2 mm Hg) groups compared with
values in normal subjects (10 ± 1 mm Hg). Peak systolic
meridional stress occurred early in ejection before the ap-
pearance of significant wall thickening, whereas at end-
ejection when wall thickness was maximal, meridional stress
had decreased substantially even though left ventricular
pressure remained at or near peak levels. Values for left
ventricular peak and mean systolic stress were similar in
normal volume-overloaded and pressure-overloaded hearts.
End-diastolic wall stress, however, was increased in patients
with volume overload compared with values in the other
two groups.
Hypothesis relating wall stress and patterns of ven-
tricular hypertrophy. These observations, coupled with
previous experimental evidence (35-37) that systolic ven-
tricular wall tension is a stimulus to hypertrophy, led Gross-
man et al. (33) to formulate the hypothesis depicted in Figure
8. According to this hypothesis, when the primary stimulus
to hypertrophy is left ventricular pressure overload, the re-
sultant acute increase in peak systolic wall stress leads to
parallel replication of sarcomeres, wall thickening and con-
centric hypertrophy. The resultant wall thickening is suf-
ficient to return peak systolic stress to normal, thus acting
as feedback inhibition of the hypertrophic process. Exper-
imental support for this hypothesis has been found in the
investigations of Sasayama et al. (38), who produced acute
pressure overload hypertrophy by aortic banding in dogs,
and observed an initial increase in systolic wall stress im-
mediately after banding that returned to normal within the
subsequent 2.5 weeks concomitant with a major increase in
left ventricular wall thickness. Sasayama et al. interpreted
the early increase in systolic wall stress as the stimulus for
subsequent hypertrophy. In contrast, when the primary stim-
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of the R wave of the electrocardiogram. Mean systolic me-
ridional stress was determined by averaging values for me-
ridional stress from end-diastole to end-systole,
Figure 7 shows the time course of changes in left ven-
tricular pressure. wall thickness and meridional stress for
representative normal, pressure-overloaded and volume-
overloaded left ventricles. Left ventricular peak systolic
pressure was significantly increased in the pressure overload
Figure 6. Meridionalwall stress calculatedthroughoutthe cardiac
cycle in a normal subject from simultaneous measurements of left
ventricular pressure, wall thickness and minor axis. Wall stress
calculated from angiographic (ANGlO) and ultrasonic (ECHO)
data showexcellent agreement, withclose superimposition of stress-
time plots constructedby the different methods. Similaragreement
was seen for pressure- and volume-overloaded ventricles. (Repro-
duced with permission from Grossman W, et al. [33].)
Figure 7. Comparison of changes in left
ventricular pressure (solid dots), wall
thickness(open dots) and meridionalstress
(open squares) throughout the cardiaccycle
for representative normal (A), pressure-
overloaded (B) and volume-overloaded (C)
left ventricles. Measurementsare plotted at
40 ms intervals. In the pressure-overloaded
ventricle (8), the markedly elevated sys-
tolic pressure is exactly counterbalanced by
increased wall thickness, with the result that
wall stress remains normal. In the volume-
overloaded ventricle (C), peaksystolic stress
is normal, but end-diastolic stress is sig-
nificantly increased. (Reproducedwith per-
mission from Grossman W, et al. [33].)TIME
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ulus to hypertrophy is left ventricular volume overload ,
increased end-diastolic wall stress leads to series replication
of sarcomeres , fiber elongation, chamber enlargement and
eccentric hypertrophy (Fig. 8). Chamber enlargement leads
acutely to increased peak systolic wall stress, which in tum
causes wall thickening of sufficient magnitude to normalize
the systolic stress . Thus , both wall thickening and fiber
elongation contribute to the pattern of eccentric hypertrophy.
Neurohumoral Factors
Among the nonmechanical factors that have been impli-
cated in the pathogenesis of myocardial hypertrophy are
genetic influences, the presence of processes that have a
deleterious influence on the myocardium (such as aging,
diabetes mellitus and cardiomyopathy), increased activity
of the renin-angiotensin system , increased circulating cate-
cholamines or discharge of the cardiac sympathetic nerves,
thyroxine and growth hormone (39,40) .
Renin-angiotensin system. Angiotensin II has been
shown to stimulate myocardial DNA, RNA and protein syn-
thesis (41) and thus is thought to play at least a permissive
role in the development of myocardial hypertrophy in hy-
pertensive states in which circulating renin levels are ele-
vated. Recent experiments (42) in liver cell preparations
have demonstrated that angiotensin II alters chromatin con-
formation in ways suggestive of enhanced transcriptional
activity, thus providing a cellular mechanism for the putative
myocardial hypertrophy effects of the renin-angiotensin sys-
tem. Moreover, treatment of hypertensive subjects with
antihypertensive drugs such as hydralazine or minoxidil ,
which tend to elevate renin levels , fails to reverse left ven-
tricular hypertrophy despite adequate control of blood pres-
sure, whereas drugs such as alpha-methyldopa and capto-
pril, which lower angiotensin II levels, cause left ventricular
Figure 8. Hypothesis relating wall stress and patterns of hyper-
trophy. (T = meridional stress. (Reproduced with permission from
Grossman W, et al. [33].)
hypertrophy to regress (43-47). The differential effects of
these agents on the myocardium may be related to factors
other than the renin-angiotensin system, such as hemody-
namics, catecholamine release and direct stimulation of myo-
cyte and connective tissue growth . Further study is needed
to define the role of renin or angiotensin, or both, in the
pathogenesis of myocardial hypertrophy in hypertension.
Increased circulating catecholamines. Several lines of
evidence have implicated catecholamines in the pathogen-
esis of cardiac hypertrophy (39,48-50). Exogenous cate-
cholamines induced myocardial hypertrophy and hypertro-
phy of cardiac myocytes maintained in culture (51,52), and
myocardial catecholamine stores and turnover are altered in
the hypertrophic heart (53). Further , long-term administra-
tion of beta-adrenergic receptor antagonists has been shown
(54) to reduce myocardial growth in normal animals (rabbits).
In contrast, the contribution of catecholamines to the
development of myocardial hypertrophy in the setting of
systemic hypertension is uncertain . Most studies (55,56)
show that long-term administration of a beta-adrenergic re-
ceptor antagonist does not prevent or cause reversal of myo-
cardial hypertrophy in hypertensive animals (rats), even when
blood pressure is lowered significantly. In addition , studies
of the effects of sympathetic denervat ion of the heart on the
development of myocardial hypertrophy have yielded con-
flicting results. Neonatal immunosympathectomy with nerve
growth factor antiserum does not prevent cardiac hypertro-
phy in the spontaneously hypertensive rat of the Okamoto
strain despite prevention of the hypertension and extensive
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depletion of myocardial norepinephrine stores (57). Simi-
larly , chemical sympathectomy with 6-hydroxydopamine
does not prevent the development of cardiac hypertrophy in
the deoxycorticosterone (acetate) (DOCA) sodium chloride
hypertensive rat, a model in which increased sympathetic
nervous system activity has been demonstrated. In contrast,
chemical sympathectomy with guanethidine has been shown
to prevent exercise-induced myocardial hypertrophy in nor-
motensive rats (58). Alpha-methyldopa, a centrally acting
antihypertensive drug that has a sympatholytic effect on the
heart , can prevent or reverse myocardial hypertrophy
(43,44,46). This agent also has effects on systemic hemo-
dynamics, myocardial contractility and the renin-angioten-
sin system, which complicate the interpretation of these data
(39). In contrast, c1onidine, an agent that has a mechanism
of action similar to that of alpha-methyldopa, does not pre-
vent or reverse myocardial hypertrophy in the spontaneously
hypertensive rat despite significant reductions in blood pres-
sure and heart rate (59) . Systemic vasodilators such as hy-
dralazine or minoxidil , which cause reflexly mediated myo-
cardial stimulation, fail to reverse or even exacerbate
myocardial hypertrophy despite adequate control of blood
pressure (43,49). Thus, the role of catecholamines in the
pathogenesis of hypertension-related myocardial hypertro-
phy is uncertain, despite the fact that activity of the cardiac
sympathetic nerves, as assessed by turnover and synthesis
of norepinephrine in the myocardium , is increased in several
animal models of hypertension.
Recently, a soluble protein-synthesis-stimulating factor
that appears to be a protein has been isolated from the
hypertrophied myocardium of the spontaneously hyperten-
sive rat (60) . Further study of this and other myocardial
growth factors may provide a biochemical basis for genet-
ically based myocardial hypertrophy.
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